The Justice Section and the SEC have a prolonged historical past of concentrating FCPA enforcement on pharmaceutical and medical product corporations. Starting off with a wide “market sweep” nearly a decade in the past, DOJ and the SEC have introduced several enforcement steps. In reaction, drug and product corporations have tried to put into action helpful compliance plans. In this Episode, Mike Volkov discusses FCPA enforcement tendencies and compliance approaches….
By: Michael Volkov